Literature DB >> 19568884

Diagnostic tumor marker of asbestos-related mesothelioma.

Okio Hino1, Masahiro Maeda.   

Abstract

Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous exposure to asbestos. The incubation period of the tumor may be described as 30-40 years, and the prognosis is dismal. We previously discovered the Erc (Expressed in renal carcinoma) gene in the Eker rat model (Tsc2 gene mutant) and it was a homolog of the human mesothelin/MPF gene. We developed a novel ELISA system (N-ERC/mesothelin). Recently, we found that N-ERC/mesothelin was a potentially useful diagnostic marker for asbestos-related mesothelioma.

Entities:  

Year:  2008        PMID： 19568884      PMCID： PMC2698268          DOI： 10.1007/s12199-007-0014-9

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN： 1342-078X            Impact factor:   3.674


  19 in total

1.  MESOMARK: a potential test for malignant pleural mesothelioma.

Authors:  Heather L Beyer; Ryan D Geschwindt; Curtis L Glover; Ly Tran; Ingegerd Hellstrom; Karl-Erik Hellstrom; M Craig Miller; Thorsten Verch; W Jeffrey Allard; Harvey I Pass; Niranjan Y Sardesai
Journal:  Clin Chem       Date:  2007-02-08       Impact factor: 8.327

Review 2.  Molecular tumor markers for asbestos-related mesothelioma: serum diagnostic markers.

Authors:  Masahiro Maeda; Okio Hino
Journal:  Pathol Int       Date:  2006-11       Impact factor: 2.534

3.  Novel ELISA system for detection of N-ERC/mesothelin in the sera of mesothelioma patients.

Authors:  Kazu Shiomi; Hideaki Miyamoto; Tatsuya Segawa; Yoshiaki Hagiwara; Akinobu Ota; Masahiro Maeda; Kazuhisa Takahashi; Kimihiko Masuda; Yukinori Sakao; Okio Hino
Journal:  Cancer Sci       Date:  2006-06-07       Impact factor: 6.716

4.  Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.

Authors:  Arnaud Scherpereel; Bogdan Grigoriu; Massimo Conti; Thomas Gey; Marc Grégoire; Marie-Christine Copin; Patrick Devos; Bachar Chahine; Henri Porte; Philippe Lassalle
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

5.  Mapping and determination of the cDNA sequence of the Erc gene preferentially expressed in renal cell carcinoma in the Tsc2 gene mutant (Eker) rat model.

Authors:  Y Yamashita; M Yokoyama; E Kobayashi; S Takai; O Hino
Journal:  Biochem Biophys Res Commun       Date:  2000-08-18       Impact factor: 3.575

6.  Mesothelin-family proteins and diagnosis of mesothelioma.

Authors:  Bruce W S Robinson; Jenette Creaney; Richard Lake; Anna Nowak; A William Musk; Nick de Klerk; Pernilla Winzell; Karl Erik Hellstrom; Ingegerd Hellstrom
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

7.  Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.

Authors:  K Chang; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

Review 8.  Diagnostic biomarker of asbestos-related mesothelioma: example of translational research.

Authors:  Hino Okio; Shiomi Kazu; Maeda Masahiro
Journal:  Cancer Sci       Date:  2007-05-25       Impact factor: 6.716

9.  Molecular cloning and expression of megakaryocyte potentiating factor cDNA.

Authors:  T Kojima; M Oh-eda; K Hattori; Y Taniguchi; M Tamura; N Ochi; N Yamaguchi
Journal:  J Biol Chem       Date:  1995-09-15       Impact factor: 5.157

Review 10.  Blood tests for asbestos-related mesothelioma.

Authors:  Masahiro Maeda; Okio Hino
Journal:  Oncology       Date:  2007-03-05       Impact factor: 2.935
View more
  4 in total

1.  Aberrant DNA methylation profile in pleural fluid for differential diagnosis of malignant pleural mesothelioma.

Authors:  Masanori Fujii; Nobukazu Fujimoto; Akio Hiraki; Kenichi Gemba; Keisuke Aoe; Shigeki Umemura; Hideki Katayama; Nagio Takigawa; Katsuyuki Kiura; Mitsune Tanimoto; Takumi Kishimoto
Journal:  Cancer Sci       Date:  2012-01-13       Impact factor: 6.716

2.  Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study.

Authors:  Jiegou Xu; David B Alexander; Masaaki Iigo; Hirokazu Hamano; Satoru Takahashi; Takako Yokoyama; Munehiro Kato; Ikuji Usami; Takeshi Tokuyama; Masahiro Tsutsumi; Mouka Tamura; Tetsuya Oguri; Akio Niimi; Yoshimitsu Hayashi; Yoshifumi Yokoyama; Ken Tonegawa; Katsumi Fukamachi; Mitsuru Futakuchi; Yuto Sakai; Masumi Suzui; Michihiro Kamijima; Naomi Hisanaga; Toyonori Omori; Dai Nakae; Akihiko Hirose; Jun Kanno; Hiroyuki Tsuda
Journal:  Cancer Sci       Date:  2015-06-05       Impact factor: 6.716

3.  Malignant peritoneal mesothelioma with lymph node metastasis that originated in the transverse colon.

Authors:  Yusuke Takehara; Shungo Endo; Yuichi Mori; Kenta Nakahara; Daisuke Takayanagi; Shoji Shimada; Tomokatsu Omoto; Chiyo Maeda; Shumpei Mukai; Eiji Hidaka; Fumio Ishida; Jun-ichi Tanaka; Shin-ei Kudo
Journal:  World J Surg Oncol       Date:  2014-04-23       Impact factor: 2.754

4.  ERC/mesothelin is expressed in human gastric cancer tissues and cell lines.

Authors:  Tomoaki Ito; Kazunori Kajino; Masaaki Abe; Koichi Sato; Hiroshi Maekawa; Mutsumi Sakurada; Hajime Orita; Ryo Wada; Yoshiaki Kajiyama; Okio Hino
Journal:  Oncol Rep       Date:  2013-10-22       Impact factor: 3.906
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.